These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 9840141

  • 1. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma.
    Shen L, Fang J, Qiu D, Zhang T, Yang J, Chen S, Xiao S.
    Hepatogastroenterology; 1998; 45(23):1753-9. PubMed ID: 9840141
    [Abstract] [Full Text] [Related]

  • 2. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma].
    Shen L, Qui D, Fang J.
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):173-6. PubMed ID: 10920889
    [Abstract] [Full Text] [Related]

  • 3. Alterations of level of total genomic DNA methylation and pattern of c-myc, c-Ha-ras oncogene methylation in human gastric carcinogenesis.
    Fang J, Zhu S, Xiao S, Shi Y, Jiang S, Zhou X, Qian L.
    Chin Med J (Engl); 1996 Oct; 109(10):787-91. PubMed ID: 9275356
    [Abstract] [Full Text] [Related]

  • 4. [Methylation status of c-fms oncogene in hepatocellular carcinoma and its relation with clinical pathology].
    Cui J, Yang D.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):137-8. PubMed ID: 11412385
    [Abstract] [Full Text] [Related]

  • 5. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
    Pascale RM, Simile MM, Feo F.
    Anticancer Res; 1993 Jun; 13(5A):1341-56. PubMed ID: 8239505
    [Abstract] [Full Text] [Related]

  • 6. Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma.
    Nambu S, Inoue K, Saski H.
    Jpn J Cancer Res; 1987 Jul; 78(7):695-704. PubMed ID: 3040653
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 8. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH.
    Clin Cancer Res; 2009 Feb 01; 15(3):812-20. PubMed ID: 19188151
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of DNA methylation pattern of c-myc oncogene in hepatocellular carcinoma].
    Xiao W, Liu W, Lu Y.
    Zhonghua Yi Xue Za Zhi; 1996 Jul 01; 76(7):501-4. PubMed ID: 9275498
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma.
    Ogata N, Kamimura T, Asakura H.
    Hepatology; 1991 Jan 01; 13(1):31-7. PubMed ID: 1846346
    [Abstract] [Full Text] [Related]

  • 12. Genome-wide hypomethylation in hepatocellular carcinogenesis.
    Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF.
    Cancer Res; 2001 May 15; 61(10):4238-43. PubMed ID: 11358850
    [Abstract] [Full Text] [Related]

  • 13. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
    Kiran M, Chawla YK, Kaur J.
    Cancer Genet Cytogenet; 2009 Dec 15; 195(2):112-9. PubMed ID: 19963110
    [Abstract] [Full Text] [Related]

  • 14. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 15. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
    Weihrauch M, Benicke M, Lehnert G, Wittekind C, Wrbitzky R, Tannapfel A.
    Br J Cancer; 2001 Apr 06; 84(7):982-9. PubMed ID: 11286481
    [Abstract] [Full Text] [Related]

  • 16. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.
    Genes Chromosomes Cancer; 2009 Dec 06; 48(12):1057-68. PubMed ID: 19760608
    [Abstract] [Full Text] [Related]

  • 17. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.
    Ai Zheng; 2006 Jun 06; 25(6):696-700. PubMed ID: 16764763
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q, Tang ZY, Qin LX, Ma ZC, Zhang LH.
    Hepatogastroenterology; 2003 Jun 06; 50(53):1579-82. PubMed ID: 14571790
    [Abstract] [Full Text] [Related]

  • 19. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 06; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.